Published in Plast Reconstr Surg on September 01, 1998
The recycling of autoclaved autografts in mandibular reconstruction: case report and review of literature. J Maxillofac Oral Surg (2013) 0.75
A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med (1995) 3.30
Rapid viral diagnosis of acute respiratory infections: comparison of enzyme-linked immunosorbent assay and the immunofluorescence technique for detection of viral antigens in nasopharyngeal secretions. J Clin Microbiol (1985) 2.69
Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol (2005) 2.04
The whereabouts of a morphogen: direct evidence for short- and graded long-range activity of hedgehog signaling peptides. Dev Biol (2001) 1.98
Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet (1993) 1.68
Healing of bone defects by guided tissue regeneration. Plast Reconstr Surg (1988) 1.63
Screening plate method for detection of bacterial beta-glucuronidase. Appl Microbiol (1973) 1.61
A case of diffuse leptomeningeal oligodendrogliomatosis associated with HHV-6 variant A. Neuropediatrics (2002) 1.59
Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS (1997) 1.57
Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections. J Clin Microbiol (1984) 1.53
Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections. J Med Virol (1987) 1.52
Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results. North American Linomide Investigators. Neurology (2000) 1.52
Sequence variation within three important cytomegalovirus gene regions in isolates from four different patient populations. J Clin Microbiol (1998) 1.43
Chronic infectious mononucleosis; a case report. J Intern Med (1989) 1.40
Relationship of urinary myelin basic protein-like material with cranial magnetic resonance imaging in advanced multiple sclerosis. Arch Neurol (2001) 1.40
Epstein-Barr virus induced thrombocytopenia treated with intravenous acyclovir and immunoglobulin. Scand J Infect Dis (1989) 1.39
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS. Neurology (2005) 1.33
Antigen detection: the method of choice in comparison with virus isolation and serology for laboratory diagnosis of herpes zoster in human immunodeficiency virus-infected patients. J Clin Microbiol (1997) 1.31
Evaluation of three commercial enzyme-linked immunosorbent assays and two latex agglutination assays for diagnosis of primary Epstein-Barr virus infection. J Clin Microbiol (1997) 1.28
Ca2+-binding studies of the phosphoprotein from rat-incisor dentine. Eur J Biochem (1981) 1.28
Case-control study on concentrations of organohalogen compounds and titers of antibodies to Epstein-Barr virus antigens in the etiology of non-Hodgkin lymphoma. Leuk Lymphoma (2001) 1.27
Nonocollagenous proteins of dentin. Isolation and partial characterization of rat dentin proteins and proteoglycans using a three-step preparative method. Coll Relat Res (1981) 1.26
Noncollagenous proteins of dentin. A re-examination of proteins from rat incisor dentin utilizing techniques to avoid artifacts. J Biol Chem (1980) 1.26
Circulating epstein-barr virus in children living in malaria-endemic areas. Scand J Immunol (2005) 1.25
Varicella-zoster virus (VZV) DNA in cerebrospinal fluid of patients infected with human immunodeficiency virus: VZV disease of the central nervous system or subclinical reactivation of VZV infection? Clin Infect Dis (1997) 1.24
Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation. Bone Marrow Transplant (1999) 1.23
Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. J Infect Dis (1986) 1.22
Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma. J Clin Microbiol (2001) 1.20
Comparative evaluation of nine kits for rapid diagnosis of infectious mononucleosis and Epstein-Barr virus-specific serology. J Clin Microbiol (1994) 1.19
Dental fear and avoidance: a comparison of two modes of treatment. J Dent Res (1984) 1.19
Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts. J Immunol (2000) 1.18
Cytomegalovirus DNA detection of an immediate early protein gene with nested primer oligonucleotides. J Virol Methods (1991) 1.18
Self-sampling for analysis of respiratory viruses in a large-scale epidemiological study in Sweden. Euro Surveill (2015) 1.13
Multiple forms of rat dentin phosphoproteins. Arch Biochem Biophys (1983) 1.13
Reduction of tension in fearful dental patients. J Am Dent Assoc (1980) 1.12
High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol (2000) 1.08
Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood (1996) 1.07
Comparative analyses of capsular fluid and interstitial fluid. Am J Physiol (1974) 1.05
Fibrinogenolytic and fibrinolytic activity in oral microorganisms. J Clin Microbiol (1983) 1.04
A monkey model for Epstein Barr virus-associated lymphomagenesis in human acquired immunodeficiency syndrome. J Exp Med (1992) 1.03
Development and evaluation of a flow-cytometric assay of specific cell-mediated immune response in activated whole blood for the detection of cell-mediated immunity against varicella-zoster virus. J Immunol Methods (2003) 1.02
Noncollagenous proteins of rat compact bone. J Biol Chem (1983) 1.02
Isoelectric focusing of the phosphoprotein of rat-incisor dentin in ampholine and acid pH gradients. Evidence for carrier ampholyte-protein complexes. J Chromatogr (1978) 1.02
Shedding of cytomegalovirus and herpesviruses 6, 7, and 8 in saliva of human immunodeficiency virus type 1-infected patients and healthy controls. Clin Infect Dis (1998) 1.02
Pretransplant herpesvirus serology and acute graft-versus-host disease. Transplantation (1988) 1.02
Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. Clin Infect Dis (2000) 1.00
Bone augmentation at fenestrated implants by an osteopromotive membrane technique. A controlled clinical study. Clin Oral Implants Res (1996) 0.98
Effects of bone wax on rabbit cranial bone lesions. J Craniomaxillofac Surg (1987) 0.98
Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis (1989) 0.98
Infrequent detection of cytomegalovirus and Epstein-Barr virus DNA in synovial membrane of patients with rheumatoid arthritis. J Rheumatol (1998) 0.98
The Russian influenza in Sweden in 1889-90: an example of Geographic Information System analysis. Euro Surveill (2008) 0.97
Detection of Epstein-Barr virus, but not human herpesvirus 8, DNA in cervical secretions from Swedish women by real-time polymerase chain reaction. Sex Transm Dis (2001) 0.97
Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? Clin Infect Dis (1999) 0.97
Viral etiology of acute childhood encephalitis in Beijing diagnosed by analysis of single samples. Pediatr Infect Dis J (1996) 0.96
Herpes simplex virus infections of the central nervous system in human immunodeficiency virus-infected patients: clinical management by polymerase chain reaction assay of cerebrospinal fluid. Clin Infect Dis (1998) 0.96
Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds. Antimicrob Agents Chemother (1990) 0.95
Ability of oral bacteria to degrade fibronectin. Infect Immun (1986) 0.95
Epstein-Barr virus and cytomegalovirus in relation to testicular-cancer risk: a nested case-control study. Int J Cancer (1999) 0.95
Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity. J Clin Virol (2001) 0.95
Seroprevalence of viral childhood infections in Eritrea. J Clin Virol (2000) 0.95
Generation of new bone around titanium implants using a membrane technique: an experimental study in rabbits. Int J Oral Maxillofac Implants (1989) 0.93
Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol Scand (1997) 0.93
Osseous response to implanted natural bone mineral and synthetic hydroxylapatite ceramic in the repair of experimental skull bone defects. J Oral Maxillofac Surg (1992) 0.93
The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly. J Clin Virol (2002) 0.92
Human cytomegalovirus, human herpesvirus-6 and human herpesvirus-7 in neutropenic patients with fever of unknown origin. Clin Microbiol Infect (2003) 0.92
Diagnosis of cytomegalovirus infections using polymerase chain reaction, virus isolation and serology. Scand J Infect Dis (1993) 0.91
A roentgen stereophotogrammetric system. Construction, calibration and technical accuracy. Acta Radiol Diagn (Stockh) (1983) 0.91
Induction and inhibition of hydroxyapatite formation by rat dentine phosphoprotein in vitro. Arch Oral Biol (1988) 0.91
Adipose tissue concentrations of dioxins and dibenzofurans, titers of antibodies to Epstein-Barr virus early antigen and the risk for non-Hodgkin lymphoma. Environ Res (2001) 0.91
Maxillary alveolar ridge augmentation with onlay bone-grafts and immediate endosseous implants. J Craniomaxillofac Surg (1992) 0.90
Mineral induction in vivo by dentine proteins. Caries Res (1993) 0.90
Osteopromotion: a soft-tissue exclusion principle using a membrane for bone healing and bone neogenesis. J Periodontol (1993) 0.90
Effects of different osteopromotive membrane porosities on experimental bone neogenesis in rats. Biomaterials (1996) 0.90
Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide: a double-blind, placebo-controlled pilot study with monthly magnetic resonance imaging evaluation. Neurology (1996) 0.90
Effects of recombinant human fibroblast growth factor-2 on osteogenic cell populations during orthopic osteogenesis in vivo. Bone (2000) 0.90
Odontoblast metabolism in rats deficient in vitamin D and calcium I: A histochemical survey. J Oral Pathol (1977) 0.90
Non-collagenous proteins of predentine from dentinogenically active bovine teeth. Biochem J (1983) 0.90
A biochemical study of alkaline phosphatase in isolated rat incisor odontoblasts. Arch Oral Biol (1972) 0.89
Human immunodeficiency virus type 1 and cytomegalovirus in saliva. J Med Virol (1993) 0.89
Detection of respiratory viruses in nasopharyngeal secretions with immunofluorescence technique for multiplex screening-an evaluation of the Chemicon assay. Clin Diagn Virol (1996) 0.89
Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study. J Med Virol (2000) 0.89
Reactivation of human herpesvirus 6 during pregnancy. J Infect Dis (1999) 0.88
Direct identification by PCR of EBV types and variants in clinical samples. J Med Virol (1997) 0.88
Healing of maxillary and mandibular bone defects using a membrane technique. An experimental study in monkeys. Scand J Plast Reconstr Surg Hand Surg (1990) 0.88
Sensitive analytic ELISAs for subclass herpes virus IgG. J Virol Methods (1985) 0.88
Prevailing effectiveness of the 2009 influenza A(H1N1)pdm09 vaccine during the 2010/11 season in Sweden. Euro Surveill (2013) 0.87
Membrane-induced bone augmentation at titanium implants. A report on ten fixtures followed from 1 to 3 years after loading. Int J Periodontics Restorative Dent (1991) 0.87
Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients. Bone Marrow Transplant (2002) 0.87
'On-off' phenomenon in Parkinson's disease: relationship between dopa and other large neutral amino acids in plasma. Neurology (1988) 0.87
Transfer and persistence of viral antibody-producing cells in bone marrow transplantation. J Infect Dis (1984) 0.87
Cytomegalovirus viraemia and specific T-helper cell responses as predictors of disease after allogeneic marrow transplantation. Br J Haematol (1993) 0.87
Concentrations of organochlorines related to titers to Epstein-Barr virus early antigen IgG as risk factors for hairy cell leukemia. Environ Health Perspect (2000) 0.87
An epidemiological survey of nephropathia epidemica in Sweden. Scand J Infect Dis (1983) 0.87
Dentin phosphoprotein sequence motifs and molecular modeling: conformational adaptations to mineral crystals. Eur J Oral Sci (1998) 0.87
Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects. J Biomed Mater Res (1997) 0.87
Cation binding by the rat-incisor-dentine phosphoprotein. A spectroscopic investigation. Eur J Biochem (1980) 0.87
Human herpesvirus-6 and cross-reactivity with other herpesviruses. Lancet (1989) 0.86
Determination of proteolytic activity: a sensitive and simple assay utilizing substrate adsorbed to a plastic surface and radial diffusion in gel. Anal Biochem (1981) 0.86